Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2024

May 7, 2024

34491_dirs_2024-05-07_7dcd4e41-7ad7-4866-bf64-401be8594bab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2024-05-04

Reporting Person: Pire Shari Lisa (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-05-04 Common Stock M 4202 Acquired 4202 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-05-04 Restricted Stock Units $ M 4202 Disposed Common Stock (4202) Direct

Footnotes

F1: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split.

F4: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024.